Literature DB >> 22975586

Muscle fiber atrophy and regeneration coexist in collagen VI-deficient human muscle: role of calpain-3 and nuclear factor-κB signaling.

Sonia Paco1, Isidre Ferrer, Cristina Jou, Victoria Cusí, Joan Corbera, Ferran Torner, Francesca Gualandi, Patrizia Sabatelli, Anna Orozco, Anna Maria Gómez-Foix, Jaume Colomer, Andres Nascimento, Cecilia Jimenez-Mallebrera.   

Abstract

Ullrich congenital muscular dystrophy (UCMD) is a common form of muscular dystrophy associated with defects in collagen VI. It is characterized by loss of individual muscle fibers and muscle mass and proliferation of connective and adipose tissues. We sought to investigate the mechanisms by which collagen VI regulates muscle cell survival, size, and regeneration and, in particular, the potential role of the ubiquitin-proteasome and calpain-proteolytic systems. We studied muscle biopsies of UCMD (n = 6), other myopathy (n = 12), and control patients (n = 10) and found reduced expression of atrogin-1, MURF1, and calpain-3 mRNAs in UCMD cases. Downregulation of calpain-3 was associated with changes in the nuclear immunolocalization of nuclear factor-κB. We also observed increased expression versus controls of regeneration markers at the protein and RNA levels. Satellite cell numbers did not differ in collagen VI-deficient muscle versus normal nonregenerating muscle, indicating that collagen VI does not play a key role in the maintenance of the satellite cell pool. Our results indicate that alterations in calpain-3 and nuclear factor-κB signaling pathways may contribute to muscle mass loss in UCMD muscle, whereas atrogin-1 and MURF1 are not likely to play a major role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975586     DOI: 10.1097/NEN.0b013e31826c6f7b

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

Review 1.  Calpain-14 and its association with eosinophilic esophagitis.

Authors:  Vladislav A Litosh; Mark Rochman; Jeffrey K Rymer; Aleksey Porollo; Leah C Kottyan; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-01-25       Impact factor: 10.793

2.  Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies.

Authors:  Renjini Ramadasan-Nair; Narayanappa Gayathri; Sudha Mishra; Balaraju Sunitha; Rajeswara Babu Mythri; Atchayaram Nalini; Yashwanth Subbannayya; Hindalahalli Chandregowda Harsha; Ullas Kolthur-Seetharam; Muchukunte Mukunda Srinivas Bharath
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

3.  Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.

Authors:  Susana Graciela Kalko; Sonia Paco; Cristina Jou; Maria Angels Rodríguez; Marija Meznaric; Mihael Rogac; Maja Jekovec-Vrhovsek; Monica Sciacco; Maurizio Moggio; Gigliola Fagiolari; Boel De Paepe; Linda De Meirleir; Isidre Ferrer; Manel Roig-Quilis; Francina Munell; Julio Montoya; Ester López-Gallardo; Eduardo Ruiz-Pesini; Rafael Artuch; Raquel Montero; Ferran Torner; Andres Nascimento; Carlos Ortez; Jaume Colomer; Cecilia Jimenez-Mallebrera
Journal:  BMC Genomics       Date:  2014-02-01       Impact factor: 3.969

Review 4.  A Comprehensive View of the Structural and Functional Alterations of Extracellular Matrix by Snake Venom Metalloproteinases (SVMPs): Novel Perspectives on the Pathophysiology of Envenoming.

Authors:  José María Gutiérrez; Teresa Escalante; Alexandra Rucavado; Cristina Herrera; Jay W Fox
Journal:  Toxins (Basel)       Date:  2016-10-22       Impact factor: 4.546

5.  Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.

Authors:  Abhinandan Batra; Donovan J Lott; Rebecca Willcocks; Sean C Forbes; William Triplett; Jahannaz Dastgir; Pomi Yun; A Reghan Foley; Carsten G Bönnemann; Krista Vandenborne; Glenn A Walter
Journal:  J Neuromuscul Dis       Date:  2020

Review 6.  A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups.

Authors:  Matthew E Randolph; Grace K Pavlath
Journal:  Front Aging Neurosci       Date:  2015-10-07       Impact factor: 5.750

Review 7.  The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Front Aging Neurosci       Date:  2014-08-29       Impact factor: 5.750

8.  Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators.

Authors:  Sonia Paco; Teresa Casserras; Maria Angels Rodríguez; Cristina Jou; Montserrat Puigdelloses; Carlos I Ortez; Jordi Diaz-Manera; Eduardo Gallardo; Jaume Colomer; Andrés Nascimento; Susana G Kalko; Cecilia Jimenez-Mallebrera
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

9.  Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.

Authors:  Irina T Zaharieva; Mattia Calissano; Mariacristina Scoto; Mark Preston; Sebahattin Cirak; Lucy Feng; James Collins; Ryszard Kole; Michela Guglieri; Volker Straub; Kate Bushby; Alessandra Ferlini; Jennifer E Morgan; Francesco Muntoni
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.

Authors:  Sonia Paco; Susana G Kalko; Cristina Jou; María A Rodríguez; Joan Corbera; Francesco Muntoni; Lucy Feng; Eloy Rivas; Ferran Torner; Francesca Gualandi; Anna M Gomez-Foix; Anna Ferrer; Carlos Ortez; Andrés Nascimento; Jaume Colomer; Cecilia Jimenez-Mallebrera
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.